Narrow your search
Listing 1 - 10 of 18 << page
of 2
>>
Sort by
Statistical issues in drug research and development
Author:
ISBN: 0824782909 Year: 1990 Volume: vol 106 Publisher: New York Basel Dekker

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Multivariate methods in drug and agrochemical research /David W. Salt, Martyn G. Ford
ISBN: 0136054110 Year: 1990 Publisher: New York Ellis Horwood

Loading...
Export citation

Choose an application

Bookmark

Abstract

Medicinal chemistry: the role of organic chemistry in drug research
Authors: ---
ISBN: 012274120X 9780122741203 Year: 1993 Publisher: London Academic Press


Book
Strategy in drug research : proceedings of the second IUPAC-IUPHAR symposium held in Noordwijkerhout, the Netherlands, August 25-28, 1981

Handbook of regression and modeling : applications for the clinical and pharmaceutical industries
Author:
ISBN: 157444610X 9781574446104 9780429113734 Year: 2007 Volume: 18 Publisher: Boca Raton: Chapman & Hall/CRC,

Frontiers in drug research: crystallographic and computational methods
Authors: ---
ISBN: 8716103912 9788716103918 Year: 1990 Volume: vol 28 Publisher: Copenhagen: Munksgaard,

Applied statistics in the pharmaceutical industry : with case studies using S-Plus
Authors: ---
ISBN: 0387988149 144193166X 1475734662 9780387988146 Year: 2001 Publisher: New York (N.Y.) : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The purpose of this book is to provide a general guide to statistical methods used in the pharmaceutical industry, and to illustrate how to use S-PLUS to implement these methods. Specifically, the goal is to: *Illustrate statistical applications in the pharmaceutical industry; *Illustrate how the statistical applications can be carried out using S-PLUS; *Illustrate why S-PLUS is a useful software package for carrying out these applications; *Discuss the results and implications of a particular application; The target audience for this book is very broad, including: *Graduate students in biostatistics; *Statisticians who are involved in the industry as research scientists, regulators, academics, and/or consultants who want to know more about how to use S-PLUS and learn about other sub-fields within the indsutry that they may not be familiar with; *Statisticians in other fields who want to know more about statistical applications in the pharmaceutical industry.


Book
Neither donkey nor horse
Author:
ISBN: 022637940X 022616991X 9780226169910 1322047138 9781322047133 9780226169880 022616988X Year: 2014 Publisher: Chicago London

Loading...
Export citation

Choose an application

Bookmark

Abstract

Neither Donkey nor Horse tells the story of how Chinese medicine was transformed from the antithesis of modernity in the early twentieth century into a potent symbol of and vehicle for China's exploration of its own modernity half a century later. Instead of viewing this transition as derivative of the political history of modern China, Sean Hsiang-lin Lei argues that China's medical history had a life of its own, one that at times directly influenced the ideological struggle over the meaning of China's modernity and the Chinese state. Far from being a remnant of China's premodern past, Chinese medicine in the twentieth century coevolved with Western medicine and the Nationalist state, undergoing a profound transformation-institutionally, epistemologically, and materially-that resulted in the creation of a modern Chinese medicine. This new medicine was derided as "neither donkey nor horse" because it necessarily betrayed both of the parental traditions and therefore was doomed to fail. Yet this hybrid medicine survived, through self-innovation and negotiation, thus challenging the conception of modernity that rejected the possibility of productive crossbreeding between the modern and the traditional. By exploring the production of modern Chinese medicine and China's modernity in tandem, Lei offers both a political history of medicine and a medical history of the Chinese state.


Book
Antibody-Drug Conjugates : The 21st Century Magic Bullets for Cancer
Authors: --- ---
ISBN: 9783319130811 3319130803 9783319130804 3319130811 Year: 2015 Publisher: Cham : Springer International Publishing : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This authoritative volume provides a holistic picture of antibody-drug conjugates (ADCs). Fourteen comprehensive chapters are divided into six sections including an introduction to ADCs, the ADC construct, development issues, landscape, IP and pharmacoeconomics, case studies, and the future of the field. The book examines everything from the selection of the antibody, the drug, and the linker to a discussion of developmental issues such as formulations, bio-analysis, pharmacokinetic-pharmacodynamic relationships, and toxicological and regulatory challenges. It also explores pharmacoecomonics and intellectual properties, including recently issued patents and the cost analysis of drug therapy. Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011). Finally, the volume presents a perspective by the editors on the future directions of ADC development and clinical applications. Antibody-Drug Conjugates is a practical and systematic resource for scientists, professors, and students interested in expanding their knowledge of cutting-edge research in this exciting field.


Book
Introduction to biological and small molecule drug research and development : theory and case studies
Authors: --- ---
ISBN: 0123977703 0123971764 9780123977700 1299592031 9781299592032 9780123971760 Year: 2013 Publisher: Waltham, Mass. : Elsevier,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Introduction to Biological and Small Molecule Drug Research and Development provides, for the first time, an introduction to the science behind successful pharmaceutical research and development programs. The book explains basic principles, then compares and contrasts approaches to both biopharmaceuticals (proteins) and small molecule drugs, presenting an overview of the business and management issues of these approaches. The latter part of the book provides carefully selected real-life case studies illustrating how the theory presented in the first part of the book is actually put i

Listing 1 - 10 of 18 << page
of 2
>>
Sort by